EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 130 filers reported holding EXELIXIS INC in Q3 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,000 | +42.9% | 300 | 0.0% | 0.01% | +25.0% |
| Q3 2017 | $7,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | +75.0% | 300 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $4,000 | +100.0% | 300 | 0.0% | 0.00% | +200.0% |
| Q2 2016 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,000 | – | 300 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |